1. Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseases. (26th March 2017) Authors: Berger, Nathan A; Besson, Valerie C; Boulares, A Hamid; Bürkle, Alexander; Chiarugi, Alberto; Clark, Robert S; Curtin, Nicola J; Cuzzocrea, Salvatore; Dawson, Ted M; Dawson, Valina L; Haskó, György; Liaudet, Lucas; Moroni, Flavio; Pacher, Pál; Radermacher, Peter; Salzman, Andrew L; Snyder, Solomo... Journal: British journal of pharmacology Issue: Volume 175:Number 2(2018) Page Start: 192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PARP inhibitors for cancer therapy. ([2015]) Editors: Curtin, Nicola J; Sharma, Ricky A Record Type: Book Extent: 1 online resource (xix, 591 pages) View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Radiotherapy biobanking: current landscape, opportunities, challenges, and future aspirations. (17th October 2021) Authors: Ward, Tim H; Gilbert, Duncan C; Higginbotham, George; Morris, Chris M; Speirs, Valerie; Curtin, Nicola J Journal: Journal of pathology Issue: Volume 8:Number 1(2022) Page Start: 3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Targeting the DNA damage response for anti-cancer therapy. (2018) Editors: Pollard, John; Curtin, Nicola J Record Type: Book Extent: 1 online resource (ix, 401 pages), illustrations (some color) View Content: Available online (eLD content is only available in our Reading Rooms) ↗